EchoGo Pro
Overview
EchoGo Pro by Ultromics is an advanced, AI-powered, cloud-based decision support tool designed to revolutionize echocardiography analysis for clinicians. It specifically aids in the accurate diagnosis of coronary artery disease (CAD) by automating the interpretation of stress echocardiograms. The platform provides near-instant, comprehensive reports, leveraging artificial intelligence models trained on extensive datasets to offer insights that enhance diagnostic accuracy and help reduce the incidence of misdiagnosis. As a module within the broader EchoGo suite, it integrates seamlessly into existing clinical workflows, supporting a vendor-neutral environment and delivering critical information directly to PACS/EHR systems without requiring on-site software installation or extensive user training.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered automated echocardiogram analysis
- Cloud-based service for accessibility and scalability
- Automated identification of coronary artery disease (CAD)
- Provides near-instant, comprehensive reports
- Improves diagnostic accuracy and reduces misdiagnosis
- Vendor-neutral system, compatible with any PACS
- Seamless integration with existing clinical workflows (DICOM, HL7)
- SaaS model requires no software installation or extensive training
- Secure by design with ISO 27001, CyberEssentials, and encryption
- Decision support for clinicians in cardiovascular imaging
Use Cases
- Diagnosing Coronary Artery Disease (CAD)
- Automating stress echocardiography analysis
- Improving diagnostic accuracy in echocardiography
- Reducing misdiagnosis in cardiovascular assessments
- Providing decision support for clinicians
- Streamlining echocardiography workflow in clinical settings
What Physicians Need to Know
EchoGo Pro offers valuable insights for CAD assessment, enhancing disease prediction and supporting more accurate diagnoses, which can facilitate earlier and more appropriate interventions. It streamlines workflow by automating echocardiogram analysis, saving clinicians time and potentially increasing patient throughput. The AI-driven analysis can significantly reduce misdiagnosis rates for CAD and provides consistent, objective results, assisting clinicians of all experience levels in interpreting stress echocardiograms. The system delivers a binary report indicating the presence or absence of CAD.
EchoGo Pro is delivered as a cloud-based Software-as-a-Service (SaaS) solution, eliminating the need for on-site software installation and extensive training. It is designed for seamless integration with existing healthcare IT infrastructure, supporting standard medical formats like DICOM for PACS integration and HL7 messaging. An API is available for customized integration needs. The platform's robust and scalable cloud-native architecture ensures secure and efficient interaction with designated systems, providing results where and when needed.
Details
| Category | Cardiology AI, Radiology & Imaging AI |
| Pricing |
Contact vendor for pricing
|
| Deployment | Cloud-based (SaaS) |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated EchoGo Pro v1.0.2 received FDA 510(k) clearance (K201555) on December 18, 2020. It is indicated as a machine learning-based decision support system, adjunct to diagnostic stress echocardiography for patients undergoing assessment for coronary artery disease (CAD). |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology |
What the Web Says
EchoGo Pro is an AI-powered, cloud-based decision support tool developed by Ultromics that assists clinicians in diagnosing coronary artery disease (CAD) by analyzing stress echocardiography images. It has received CE mark approval in the UK and EU and FDA clearance in the US. The technology aims to improve diagnostic accuracy, reduce misdiagnosis, and streamline workflow for healthcare providers. While a recent randomized controlled trial (PROTEUS study) did not show meaningful differences in the primary endpoint for all patients, further analysis suggested potential benefits for less experienced clinicians and in cases with difficult-to-interpret scans.
Overall: PositiveStrengths
- Improved diagnostic accuracy and prediction of heart disease risk.
- Reduces misdiagnosis of cardiovascular disease.
- Provides near-instant reports, saving valuable time for doctors and streamlining hospital workflow.
- Cloud-based service with zero variability between operators.
- Can provide additional insights from AI models trained on large datasets.
- Potential to benefit less experienced clinicians and in difficult-to-interpret cases.
Limitations
- One randomized controlled trial (PROTEUS study) did not show meaningful differences in the primary endpoint for all patients.
- Not intended for assessment of mild or moderate myocardial ischemia, localization of CAD, myocardial perfusion, myocardial viability, or valve disease.
- Patient management decisions should not be made solely on the results of EchoGo Pro analysis.
- Has not been validated on patients who underwent previous coronary artery bypass graft (CABG) surgery.
Based on reviews from: Ultromics CE mark's EchoGo Pro, FDA Clears Ultromics Echocardiography AI for Automated Identification of Coronary Artery Disease - Diagnostic and Interventional Cardiology, EchoGo Pro - HealthAidb u2014 Software, December 18, 2020 Ultromics Ltd. Mr. Neela Hassanali Head of Regulatory 4630 Kingsgate, Cascade Way, Oxford Business Park So - accessdata.fda.gov, Evaluating artificial intelligence-driven stress echocardiography analysis system (EASE study): A mixed method study - PMC, Ultromics: Next-generation Echocardiography is here, Ultromics receives FDA clearance for EchoGo Pro; a first-of-kind solution to help diagnose CAD, Ultromics Reviews, Pricing, Features & Integrations - Elion Health, Ultromics's EchoGo misses primary endpoint in heart disease trial - Clinical Trials Arena, Artificial intelligence improves coronary artery disease detection, new study finds, AI-driven tools into echocardiography practice : r/cardiacsonography - Reddit, Ultromics?s EchoGo did not meet primary endpoint in heart disease trial - IGMPI, FDA Clears Ultromics Echocardiography AI for Auto Identification of Coronary Artery Disease | Imaging Technology News, EchoGo Pro - Ultromics - Health AI Register, Ultromics | Ground-breaking cloud AI automation for echo analysis - Bsecho.org
Last updated: 2026-07-20
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate EchoGo Pro
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for EchoGo Pro.
Sentara Healthcare & PatientSecure, Ultromicsu2019 EchoGo Core, Alcidionu2019s 1st mobile EMR
Health2Tech
Frequently Asked Questions
Compare EchoGo Pro
VS
VS
VS
VS
